Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v8-FR
Language English French
Date Updated 2017-10-17 2017-08-29
Drug Identification Number 02238525 02238525
Brand name HP-PAC HP-PAC
Common or Proper name Lansoprazole, Clarithromycin, Amoxicillin Lansoprazole, Clarithromycin, Amoxicillin
Company Name TAKEDA PHARMACEUTICALS AMERICA INC TAKEDA PHARMACEUTICALS AMERICA INC
Ingredients AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET
Route of administration ORAL ORAL
Packaging size HP-PAC 7-Day HP-PAC 7-Day
ATC code A02BD A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-10-05
Actual start date 2017-09-21
Estimated end date 2017-10-13 2017-10-20
Actual end date 2017-10-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Resolved on Oct 16, 2017
Health Canada comments